Mimedx Group Stock Technical Analysis
| MDXG Stock | USD 5.17 0.02 0.39% |
As of the 12th of February 2026, MiMedx secures the risk adjusted performance of (0.20), and Mean Deviation of 1.86. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MiMedx Group, as well as the relationship between them. Please verify MiMedx Group information ratio and skewness to decide if MiMedx Group is priced some-what accurately, providing market reflects its recent price of 5.17 per share. Given that MiMedx Group has information ratio of (0.30), we recommend you to check MiMedx's last-minute market performance to make sure the company can sustain itself at a future point.
MiMedx Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as MiMedx, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MiMedxMiMedx's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.MiMedx Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 10.4 | Strong Buy | 5 | Odds |
Most MiMedx analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand MiMedx stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of MiMedx Group, talking to its executives and customers, or listening to MiMedx conference calls.
Can Biotechnology industry sustain growth momentum? Does MiMedx have expansion opportunities? Factors like these will boost the valuation of MiMedx. Expected growth trajectory for MiMedx significantly influences the price investors are willing to assign. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating MiMedx demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth 1.138 | Earnings Share 0.27 | Revenue Per Share | Quarterly Revenue Growth 0.353 | Return On Assets |
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that MiMedx's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MiMedx represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, MiMedx's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
MiMedx 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MiMedx's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MiMedx.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in MiMedx on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding MiMedx Group or generate 0.0% return on investment in MiMedx over 90 days. MiMedx is related to or competes with GeoVax Labs, BioLineRx, Tharimmune, Ainos, and Lipocine. MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare More
MiMedx Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MiMedx's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MiMedx Group upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.30) | |||
| Maximum Drawdown | 10.23 | |||
| Value At Risk | (4.28) | |||
| Potential Upside | 3.21 |
MiMedx Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MiMedx's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MiMedx's standard deviation. In reality, there are many statistical measures that can use MiMedx historical prices to predict the future MiMedx's volatility.| Risk Adjusted Performance | (0.20) | |||
| Jensen Alpha | (0.66) | |||
| Total Risk Alpha | (0.91) | |||
| Treynor Ratio | (2.62) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MiMedx's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
MiMedx February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.20) | |||
| Market Risk Adjusted Performance | (2.61) | |||
| Mean Deviation | 1.86 | |||
| Coefficient Of Variation | (382.81) | |||
| Standard Deviation | 2.39 | |||
| Variance | 5.69 | |||
| Information Ratio | (0.30) | |||
| Jensen Alpha | (0.66) | |||
| Total Risk Alpha | (0.91) | |||
| Treynor Ratio | (2.62) | |||
| Maximum Drawdown | 10.23 | |||
| Value At Risk | (4.28) | |||
| Potential Upside | 3.21 | |||
| Skewness | (0.36) | |||
| Kurtosis | 0.4398 |
MiMedx Group Backtested Returns
MiMedx Group has Sharpe Ratio of -0.26, which conveys that the firm had a -0.26 % return per unit of volatility over the last 3 months. MiMedx exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify MiMedx's mean deviation of 1.86, and Risk Adjusted Performance of (0.20) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.24, which conveys not very significant fluctuations relative to the market. As returns on the market increase, MiMedx's returns are expected to increase less than the market. However, during the bear market, the loss of holding MiMedx is expected to be smaller as well. At this point, MiMedx Group has a negative expected return of -0.57%. Please make sure to verify MiMedx's total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if MiMedx Group performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.35 |
Poor reverse predictability
MiMedx Group has poor reverse predictability. Overlapping area represents the amount of predictability between MiMedx time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MiMedx Group price movement. The serial correlation of -0.35 indicates that nearly 35.0% of current MiMedx price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.35 | |
| Spearman Rank Test | -0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 0.37 |
MiMedx technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
MiMedx Group Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for MiMedx Group across different markets.
About MiMedx Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of MiMedx Group on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of MiMedx Group based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on MiMedx Group price pattern first instead of the macroeconomic environment surrounding MiMedx Group. By analyzing MiMedx's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of MiMedx's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to MiMedx specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 61.16 | 58.41 | 67.17 | 72.28 | PTB Ratio | 7.16 | 7.32 | 8.42 | 8.0 |
MiMedx February 12, 2026 Technical Indicators
Most technical analysis of MiMedx help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for MiMedx from various momentum indicators to cycle indicators. When you analyze MiMedx charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.20) | |||
| Market Risk Adjusted Performance | (2.61) | |||
| Mean Deviation | 1.86 | |||
| Coefficient Of Variation | (382.81) | |||
| Standard Deviation | 2.39 | |||
| Variance | 5.69 | |||
| Information Ratio | (0.30) | |||
| Jensen Alpha | (0.66) | |||
| Total Risk Alpha | (0.91) | |||
| Treynor Ratio | (2.62) | |||
| Maximum Drawdown | 10.23 | |||
| Value At Risk | (4.28) | |||
| Potential Upside | 3.21 | |||
| Skewness | (0.36) | |||
| Kurtosis | 0.4398 |
MiMedx February 12, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as MiMedx stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.03 | ||
| Daily Balance Of Power | (0.12) | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 5.23 | ||
| Day Typical Price | 5.21 | ||
| Price Action Indicator | (0.06) | ||
| Market Facilitation Index | 0.17 |
Complementary Tools for MiMedx Stock analysis
When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |